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Abstract
The pathological study of the placenta is of upmost importance in cases of unexplained fetal/perinatal loss and
often these carry litigation implications. Integrating pathological findings and the underlying pathophysiological
processes, leading to placental lesions, is fundamental for the evaluation of poor fetal and perinatal outcomes and to
distinguish from cases of true negligence.
Keywords: Placenta; Litigation process; Pathology study;
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Overall Perspective
Understanding the placental function has been crucial for a clinical
and well-founded interpretation of pathological alterations associated
with poor obstetric outcomes. The anatomopathological study of the
placenta allows the investigation of unforeseen cases of fetal/perinatal
loss, while further developing our knowledge of some neonatal
diseases. The significance of this study is even greater if one considers
that about 3/1,000 children will suffer of some sort of cerebral palsy
[1-4]. The increase of litigation processes towards hospitals and
obstetricians is a reality and in most cases, the litigant part claims
negligence. Setting aside, well documented cases of true negligence,
one must consciously and responsibly select cases with pathology
associated with a poor obstetric outcome. For this purpose, the study
of the placental is fundamental [5]. It is important to note that, the aim
of this article is not to describe any epidemiological study of specific
cases of placental disorders but, to emphasize that the study of the
placenta may reveal undiagnosed or unsuspected pathologies in cases
of poor obstetric outcomes that explains and justifies fetal/perinatal
loss.
Placental pathological features and adverse fetal outcome
Implantation anomalies can lead to velamentous cord insertion with
or without vasa previa, to placental accrete and/or to placenta previa
and it is well documented its relationship with neurological damage
and increased risk of fetal loss [6,7].
Placental infarction is a pathological condition of unknown etiology
with distinctive features and has been associated with fetal intrauterine
growth retardation (IUGR), microcephaly and neurological
complications [1,8].
Decidual arteriopathy is a type of injury diagnosed only
histologically and usually occurs as result of maternal circulatory
disorders, such as pre-eclampsia, hypertension, antiphospholipidic
syndrome and thrombophilia. It is also associated with placental poor
perfusion and low weight, leading to IUGR [6,9]. The period of time
that, placental lesions take to evolve and extend, and how they become
installed are determining factors for fetal complications. The most
common example is the abrupt placenta, a serious condition in which,
the time period taken to develop a retroplacental hematoma is crucial
for the macroscopic interpretation of the lesion and is critical to
understand fetal complications. When fetal death does not occur,
neurological damage is usually frequent [2,3]. Similarly, placental
infarctions have consequent fetal complications according to the time
of occurrence, location, extension and its progression. Massive
perivillous fibrin deposition is the main diagnostic features of maternal
floor infarction, a placental lesion reported to be as high as 1 of 200
placentas. The cause is unknown but, congenital infection, immune-
mediated rejection and abnormal extravillous trophoblastic
proliferation have been suggested etiologies in part because of its
recurrent nature.
Fetal vessel thrombosis is a type of lesion singularly diagnosed with
histology and greatly related to prematurity and increased incidence
on fetal thrombosis and neonatal neurological complications [4,8,10].
Infections are common and highly contagious situations, with infra-
clinical rates in 10% to 15%. It may reach the placenta and fetus in
several ways: by ascension from tract vaginal infections, by
hematogenous transmission from maternal blood by direct
introduction via amniocentesis, chorionic villus sampling and other
invasive diagnostic procedure or by direct extensions from infection in
the endometrium. It is well known an association with fetal loss and
cerebral palsy [7]. Hematogenous infection can result in fetal loss due
to anemia following Parvovirus B19 infection or lead to severe fetal
disease due to toxoplasmosis and/or cytomelovirus (CMV) infection
[11,12]. Definitive diagnosis of an infectious disease can be established
by histological observation of a characteristic inflammatory infiltrate
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and of pathognomonic viral inclusions associated with CMV and
parvovirus infection. When, morphological criteria are not fully
present, the study should be completed with immunohistochemistry or
other laboratory techniques, such as molecular analysis. The
ascending/adjacent infection is a subclinical condition that is present
in about 20% of cases. Of these, histology analysis allows the diagnosis
of acute/subacute chorioamnionitis and should always be classified
according to the stage, degree and as possible with dating time
evolution by the presence of hemosiderin. Chronic chorioamnionitis is
a medical condition with pathogenesis not yet determined and
diagnosed only with histological examination. This condition has been
demonstrated to be associated with maternal hypertension, diabetes,
IUGR, oligohydramnios, hydrops fetalis and poor perinatal evolution
[13,14].
Massive chronic intervillositis is a medical condition also singularly
diagnosed with histology and is associated with IUGR and fetal death
and commonly described in recurrent abortions. In 70% of cases, this
condition is present simultaneously with chronic villitis and is related
to prematurity and neurological injury [15]. Chronic villitis occurs in
5% to 10% of all placentas and higher percentage is well documented
when placenta of complicated pregnancies are studied. At times
infectious etiology is apparent however, in majority of cases no specific
etiology is elicited and the term villitis of unknown etiology (VUE) is
used. There are no doubts that VUE is a recurrent lesion with
occurrence rates of 10% to 25%. Two theories are postulated with
respect to the etiology of VUE. One suggest that is an infectious
disease caused by a yet unrecognized agent and other suggest an
immune reaction supported by the preferential localization of these
lesion and type of inflammatory cells. VUE is also associated with
prematurity, abnormal neurologic development and intra-uterine fetal
demise [16].
The etiology of “ADAM complex” (amniotic deformities, adhesions
and mutilations) is widely discussed as its incidence is difficult to
document and studies suggest a rate of 1/2,500 to 1/10,000 newborns.
Amnion rupture will cause, by mechanical way, amniotic bands or
sheets, leading to fetal amputations, anomalies or even demise. The
amnion rupture etiology is unknown however, it is important to note
that this is usually nonrecurring but the fetal pathological condition is
presented with a varied pattern related with the time of occurrence and
can result in severe malformations if it occurs prematurely, mimicking
trisomy 13 phenotype, or minor malformations sometimes not
prenatally detected.
On the other hand, the color change in the placenta has a distinct
pathogenesis. About 20% of newborns present a green placenta related
to meconium and it is believed that fetal distress is due to
vasoconstrictor effect, inducing vascular muscle cell necrosis and
compromising the return of the venous oxygenated placental blood
[17,18]. In premature newborns, the same color can translate in
hemosiderin deposits associated with retromembranous hematoma,
with risk of fetal-maternal transfusion, fetal hemolysis and
thrombocytopenia [19]. In turn, the alteration in parenchyma color
reflects the hemoglobin content of the villi and, when pale, usually
translates in fetal hydrops/anemia, with heterogeneous etiology and
regularly in neurological damage.
Villi morphology when histologically evaluated is correlated with
gestational age and deviation from normal development is usually
classified as: (i) maturation arrest/delay, reflecting maternal or fetal
pathology and (ii) advanced maturity, reflecting poor perfusion and
low weight with fetal/neonatal hypoxia and death[15,20]. When fetal
death occurs, determining time of death in utero is always important
and is based in macroscopic and histological changes of the placenta
and fetus [21,22].
Chorangiosis is an alteration that results from an abnormal
proliferation and capillary neovascularization process associated with
prolonged fetal hypoxia and even though the significance and
integration into the fetal-placental unit is not completely understood,
recent studies have shown its correlation with perinatal complications
[23].
Erythroblastosis usually correlates with hypoxia, infections,
bleeding and hemolytic anemia and it can be associated with genetic or
epigenetic disorders, being also described as a secondary effect of
trauma [19,24].
Fetal injuries in cases of mesenchymal dysplasia are well reported
and it is known that about 1-2% of this change, often unsuspected, is
associated with placental mosaicism [25].
The intrinsic placental lesions correspond mostly to primary
tumors, where chorangioma is the most frequent and have an
increased risk of fetal morbidity/mortality. Gestational trophoblastic
diseases are not true neoplasm. However, they are associated with an
increased risk for the development of neoplasm, specifically
choriocarcinoma. Other gestational trophoblastic disease like placental
site nodule and exaggerated placental site, are not grossly identifiable,
unlike placental site trophoblastic tumor (PSTT) and epithelioid
trophoblastic tumor (ETT) are generally evident as infiltrative masses.
Usually these situations do not pose any problem in litigation process.
Chorangioma and gestational trophoblastic disease require an
appropriate clinical follow-up due to the risk of recurrence and
malignancy, or even more aggressive disease like can occurs in PSTT
and ETT.
In twin pregnancies, in order to understand the origin of fetal
lesions and repercussions, it is essential that the physician provides
adequate a referencing of fetal umbilical cord. It is the pathologist’s
responsibility to document: (i) the relationship between membranes/
division septum and their correlation with the chorionic/vascular
equator, and chorionicity; (ii) the presence of vascular anastomosis
(VA) with or without criteria for twin-to-twin transfusion syndrome
(TTTS) and (iii) the relationship and insertion type of umbilical cords.
Both cord’s pathology and pathology related to the presence of VA are
well documented and understood. Secondary vasculogenic organ
damage and destructive lesions can occur in the survivor after fetal
death of one twin, particularly in monochorionic twins, while
polyhydramnios and oligohydramnios are most frequently found in
chronic TTTS and yet justify the discrepancy of fetal growth [25].
What type of placentas should one select for the
anatomopathological study?
Selecting a cohort of placentas to study it is not a consensual matter
and may be based on specific clinical criteria, consist in macroscopic
examination of all placentas and microscopic study of specific cases or
be restricted to cases of fetal/perinatal complications with/without
diagnosed or suspected maternal problems [26,27].
It is essential that the selection of placentas is accompanied by the
complete clinical information for the diagnostic to be integrated and
useful. The obstetrician should gather/provide all relevant clinical
information and a list of issues to clarify; while the pathologist is
responsible for studying the placenta to establish a diagnosis that
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integrates pathological findings with clinical implications [27-30]. The
pathological diagnosis should be integrated considering: (i) maternal
age and invasive diagnostic and therapeutic procedures, including
medically assisted reproduction techniques; (ii) gestational age and
maturation-related deviations and (iii) traumatic injuries, including
road traffic accidents, which many times present clinicopathological
features similar to other conditions such as abrupt placenta,
infarctions, hemorrhagic villitis and/or intra-amniotic hemorrhage
[6,27,31].
Conclusion
The development of standard guidelines and multidisciplinary
clinical consensus would allow the establishment of an accurate
protocol and reproductive methodologies that would assist in
estimating adequate criteria for subsequent actions. Table 1 reports
some situations with clinical indication for the anatomopathological
study of the placenta [32] (Table 1).
Maternal Diabetes Fetal/Neonatal Placenta,
membranes and
umbilical cords
Pregnancy-induced or
chronic hypertension
Fetal or neonatal death Infarctions, including
infarction of the
placental bed
Premature Rupture of
Membranes
Twin pregnancy Placental abruption
Preterm birth (<36
weeks)
Prematurity Vasa previa
Post-term birth (>42
weeks)
Intrauterine growth
retardation (IUGR)
Placenta previa
Poor obstetric history Hydrops Any abnormal
appearance of the
umbilical cord
membranes or of the
placenta
Unexplained fever or
infection
Congenital anomalies
Oligohydramnios Fetal/neonatal
erythroblastosis
History of drug use Not reassuring fetal status /
transfer to neonatal care unit
Ominous heart rate
Meconium discharge
Low Apgar score (<5 at 1'
and <7 at 5')
Table 1: Indications for anatomopathological study of the placenta.
In litigation processes, the pathologist is frequently called upon and
questioned to clarify specific pathological processes and their
evolution. The progress of infectious, thrombotic/ischemic events and
the establishment of fetal time of death are questions frequently
requested. These issues are sometimes challenging to assess due to the
coexistence of competing injuries, requiring a confident understanding
of its pathogenesis and implications. A cautious pathologist should
minimize possible errors, always integrating the complexity of
processes, thus avoiding an unfounded opinion that may be disputed.
It is essential to establish a good communication conduct between
obstetrician and pathologist for the production of a clinically
integrated and consistent report.
Keypoints
The progress on the knowledge and understanding placenta’s
function and its associated pathophysiological processes has allowed
the placenta to become a reflection of intrauterine life.
The placenta’s anatomopathological study is fundamental for the
integration and comprehension of poor obstetric outcomes and plays
an important role in litigation processes.
A functionally and macroscopically normal placenta can coexist
with an adverse intrauterine environment and be the cause of fetal loss.
The anatomopathological diagnosis of the placenta should integrate
lesions and its progression with consequent clinical implications.
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